Parexel and Kyoto University Hospital Announce Strategic Alliance
20 oct. 2021 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Angion to Present Multiple Posters at Kidney Week 2021
18 oct. 2021 16h05 HE
|
Angion Biomedica Corp.
UNIONDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel...
Phathom Pharmaceuticals Announces Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial
18 oct. 2021 07h00 HE
|
Phathom Pharmaceuticals
Vonoprazan met its primary non-inferiority endpoints in both healing and maintenance phasesVonoprazan demonstrated superior healing rates in patients with moderate-to-severe disease at Week 2 versus...
Informa Pharma Intelligence Partners with ICON to Launch an Integrated Predictive Analytic Solution for Clinical Trial Feasibility
13 oct. 2021 09h00 HE
|
Informa Business Intelligence
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, today announced its partnership with ICON plc, one of...
Endonovo Therapeutics Issues Shareholder Update
12 oct. 2021 16h05 HE
|
Endonovo Therapeutics, Inc.
High-Growth Acquisition Approaches Completion, Expected To Augment Core Business And Drive Long-Term Shareholder Value Los Angeles, CA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc....
Ehave Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, Florida
12 oct. 2021 08h30 HE
|
Ehave
MIAMI, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has...
vTv Therapeutics Announces Positive Results from Mechanistic Study Indicating No Increased Risk of Ketoacidosis with TTP399 during Acute Insulin Withdrawal in Patients with Type 1 Diabetes
12 oct. 2021 07h30 HE
|
vTv Therapeutics Inc.
Study achieved primary endpoint of non-inferiority on measurement of key blood ketone levels Patients taking TTP399 reported no events of hypoglycemia, while four events of hypoglycemia were reported...
Global Coronavirus Disease (COVID-19) Clinical Trials Report 2021: Overview of Trial Numbers and their Average Enrollment in Top Countries
12 oct. 2021 05h53 HE
|
Research and Markets
Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H2, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. The...
Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Anticipated to Grow Globally at a CAGR of 23.6% during 2021-26
11 oct. 2021 07h13 HE
|
Research and Markets
Dublin, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The "Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Research Report: Forecast (2021-2026)" report has been added to...
Global Clinical Trial Kits Market (2021 to 2028) - Featuring Charles River Laboratories, Almac and Alpha Laboratories Among Others
08 oct. 2021 04h33 HE
|
Research and Markets
Dublin, Oct. 08, 2021 (GLOBE NEWSWIRE) -- The "Clinical Trial Kits Market Size, Share & Trends Analysis Report By Service (Kitting Solutions, Logistics), By Phase (Phase I, Phase II, Phase III,...